Registry of Lobbyists
Version 2 of 2 (2006-10-17 to 2007-04-17) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Consultant lobbyist name: | WILLIAM DEMPSTER Lobbyist business address |
| Consulting firm: |
GLOBAL PUBLIC AFFAIRS
50 O'CONNOR ST. SUITE 901 OTTAWA, ON K1P 6L2 Canada |
| Position: | Senior Consultant |
| Telephone number: | 613-783-3455 |
| Fax number: | 613-782-2428 |
| Former public office holder: | Yes |
| Payment is contingent on the success of the undertaking: | No |
| Client: |
ALTANA PHARMA CANADA
435 NORTH SERVICE RD. W. 1ST FLOOR OAKVILLE, ON L6M 4X8 Canada |
| Telephone number: | 905-469-5427 |
| Client Representative: |
ROBERT
TAM
|
| The client is a subsidiary of the following parent companies: |
ALTANA PHARMA AG
BYK-GULDEN-STR. 2 KONSTANZ 78467 Germany |
| Coalition: | The client is not a coalition. |
| The client has the following subsidiaries which have a direct interest in the lobbying activities: |
THE P.D. GEORGE COMPANY
5200 NORTH SECOND STREET ST LOUIS, MO United States of America 63147 |
| Individual, organization or corporation: | The client's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
| Was the client funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Foreign Affairs and International Trade Canada (DFAITC), Health Canada (HC), Industry Canada, Patented Medicine Prices Review Board (PMPRB), Privy Council Office (PCO) | ||||||
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format | ||||||
| Subject Matter: Areas of Concern: | Health, Industry, Intellectual Property, International Trade, Science and Technology | ||||||
Details Regarding the Identified Subject Matter
|
|||||||